Inspire Veterinary Partners, INC 8-K filings
Inspire Veterinary Partners has received a notice from Nasdaq regarding non-compliance with minimum bid price requirements and a prior failure to obtain shareholder approval for a securities offering.
Inspire Veterinary Partners has secured $2.5 million through a registered direct offering of common stock and pre-funded warrants.
Inspire Veterinary Partners amended warrants to reduce the exercise price for a holder and held its annual meeting, electing directors and ratifying the appointment of its auditor.
Inspire Veterinary Partners received a notice from Nasdaq stating that a recent public offering did not meet shareholder approval requirements, adding to the reasons for potential delisting.
8-K: Inspire Veterinary Partners Sells Kauai Clinic for $2.16 Million to Consolidate Mainland Operations
Inspire Veterinary Partners sold its Kauai Veterinary Clinic for $2.16 million to consolidate its operations to the mainland, receiving no proceeds after paying off the clinic's loan.
Inspire Veterinary Partners has extended CEO Kimball Carr's employment agreement and established a new board steering committee to support company operations.
Inspire Veterinary Partners successfully closed a public offering, raising $6 million through the sale of units consisting of common stock or pre-funded warrants and warrants.
Inspire Veterinary Partners has been granted a Nasdaq listing extension until September 4, 2024, contingent on filing a registration statement for a public offering by June 15, 2024, and demonstrating compliance with listing rules by September 4, 2024.
8-K: Inspire Veterinary Partners Announces 100-for-1 Reverse Stock Split to Regain Nasdaq Compliance
Inspire Veterinary Partners has approved a 100-for-1 reverse stock split to increase its share price and regain compliance with Nasdaq listing requirements.
Inspire Veterinary Partners has received a notification from Nasdaq that it no longer meets the listing requirements due to a stockholders' equity deficiency of ($788,259) reported in its 2023 annual report.
Inspire Veterinary Partners has entered into a securities purchase agreement to issue $500,000 in senior notes to investors, with the funds intended for working capital and acquisitions.
Inspire Veterinary Partners, Inc. received a delisting notice from Nasdaq due to its stock price falling below $0.10 for ten consecutive days and plans to appeal and implement a reverse stock split.
Inspire Veterinary Partners issued stock to a consultant and several former owners of an acquired business to settle claims and compensate for services.
Inspire Veterinary Partners has formalized an employment agreement with its Chief Financial Officer, Richard Frank, effective January 1, 2024, outlining his compensation, duties, and terms of employment.
Inspire Veterinary Partners issued 1,214,293 shares of Class A common stock and a warrant to purchase 1,654,889 shares to Tumim Stone Capital as part of a prior agreement.
Inspire Veterinary Partners has successfully closed a public offering, raising approximately $4 million before expenses.
Inspire Veterinary Partners has successfully priced a $4 million public offering to support strategic acquisitions and business development.